Dexycu Injection, Suspension
Product Images NDC 71879-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Dexycu (NDC 71879-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eyepoint Pharmaceuticals Us, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Dexycu 01)

Figure (Dexycu 01)
DEXYCU is a suspension with a 9% concentration. The dosage is 0.005 L per administration.*
FDA Label Image

Figure (Dexycu 02)

FDA Label Image

Figure (Dexycu 03)

FDA Label Image

Figure (Dexycu 04)

FDA Label Image

Figure (Dexycu 05)

FDA Label Image

Figure (Dexycu 06)

FDA Label Image

Figure (Dexycu 07)

FDA Label Image

Figure (Dexycu 08)

FDA Label Image

Figure (Dexycu 09)

FDA Label Image

Figure (Dexycu 10)

FDA Label Image

Figure (Dexycu 11)

FDA Label Image

Figure (Dexycu 12)

FDA Label Image

Chemical Structure (Dexycu 13)

FDA Label Image

Principal Display Panel (0.005 mL Vial Carton)

Principal Display Panel (0.005 mL Vial Carton)
This is a description of the prescription medication DEXYCU, which is a dexamethasone intraocular suspension used for intraocular administration. It comes in a single-dose vial with 0.005mL per dose. The full prescribing information is enclosed in the package. The text also includes mentions of Fortobramcbafctin, NOC number, and some unrelated character strings, but they do not provide any useful information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.